Altimmune (ALT) Current Deferred Revenue (2011 - 2018)
Altimmune (ALT) posted quarterly Current Deferred Revenue of $173952.0 for Q3 2018, up 780.64% year-over-year from $19753.0 in Q3 2017, and up 0.89% quarter-over-quarter from $172414.0 in Q2 2018.
Altimmune (ALT) Current Deferred Revenue (2011 - 2018) Analysis & Trends
Altimmune (ALT) has reported Current Deferred Revenue for 7 consecutive years, with $173952.0 the latest figure, recorded in Q3 2018.
- In Q3 2018, Current Deferred Revenue rose 780.64% year-over-year to $173952.0; the TTM figure through Sep 2018 stood at $173952.0 (up 780.64% YoY), while the FY2017 annual figure was $15914.0, down 19.44% from the prior year.
- Current Deferred Revenue rose to $173952.0 in Q3 2018 per ALT's latest filing, from $172414.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $173952.0 in Q3 2018 and bottomed at $15914.0 in Q4 2017.
- Historically, Current Deferred Revenue has averaged $67631.6 across 4 years, with a median of $38503.0 in 2017.
- Annual changes were most pronounced in 2014 — Current Deferred Revenue slumped 92.88% — and 2018, when it jumped 780.64%.
- Altimmune's Current Deferred Revenue stood at $62261.0 in 2014, then sank by 68.27% to $19753.0 in 2016, then dropped by 19.44% to $15914.0 in 2017, then soared by 993.08% to $173952.0 in 2018.
- Business Quant data shows ALT's Current Deferred Revenue at $173952.0 in Q3 2018, $172414.0 in Q2 2018, and $44753.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Altimmune | 571.75 Mn | 571.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 173,952.00 |
| Jun 30, 2018 | 172,414.00 |
| Mar 31, 2018 | 44,753.00 |
| Dec 31, 2017 | 15,914.00 |
| Sep 30, 2017 | 19,753.00 |
| Jun 30, 2017 | 32,253.00 |
| Dec 31, 2016 | 19,753.00 |
| Mar 31, 2014 | 62,261.00 |
| Dec 31, 2013 | 341,723.00 |
| Sep 30, 2013 | 471,816.00 |
| Jun 30, 2013 | 508,175.00 |
| Mar 31, 2013 | 874,404.00 |
| Dec 31, 2012 | 1.38 Mn |
| Dec 31, 2011 | 514,312.00 |